← Eichor
Study identifier: NCT06059586 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

Condition: Dyspareunia · Pelvic Pain · Sexual Dysfunction  ·  Sponsor: Indiana University

PhaseNA
Planned participants20
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to examine the feasibility of adding pre-rehabilitation pelvic health physical therapy to standard of care radiation therapy treatment plan for female patients who have been diagnosed with cervical, vaginal, vulvar, uterine, or anal cancer and are a candidate for curative pelvic radiation with external beam. Participants will receive education on using a vaginal dilator for use during treatment and complete questionnaires looking at pain and sexual function.

This description comes directly from the study's public registry record.

Talk to the study team

Namita Agrawal, MD  ·  (317)944-2524  ·  agrawaln@indiana.edu

Sarah Dutkevich, RN  ·  (317)278-5618  ·  sdutkevi@iu.edu

Always discuss trial participation with your own doctor first.

Locations (3)

IU Health WestAvon, Indiana, United StatesRecruiting
IU Health Schwarz Cancer CenterCarmel, Indiana, United StatesRecruiting
Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, Indiana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06059586